Nell peptide expression systems and bone formation activity of nell peptide
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
C12N-005/10
C12N-001/21
C12N-015/63
C12N-015/12
출원번호
UP-0544553
(2004-02-09)
등록번호
US-7544486
(2009-07-01)
우선권정보
US-PCT/US03/28281(2003-09-09)
국제출원번호
PCT/US04/003808
(2004-02-09)
§371/§102 date
20060515
(20060515)
국제공개번호
WO04/072100
(2004-08-26)
발명자
/ 주소
Ting, Kang
Kuroda, Shunichi
Wu, Ben
출원인 / 주소
The Regents of the University of California
대리인 / 주소
Squire Sanders & Dempsey LLP
인용정보
피인용 횟수 :
6인용 특허 :
19
초록▼
The invention generally relates to a bone growth factor, and more particularly to compositions including NELL1, articles of manufacture including NELL1 and methods of using NELL1 to induce bone formation. This invention also provides methods for the expression and purification of NELL1 and NELL2 pep
The invention generally relates to a bone growth factor, and more particularly to compositions including NELL1, articles of manufacture including NELL1 and methods of using NELL1 to induce bone formation. This invention also provides methods for the expression and purification of NELL1 and NELL2 peptides.
대표청구항▼
What is claimed is: 1. A method of expressing a functional peptide in a mammalian cell, said method comprising: providing a nucleic acid construct including at least a nucleic acid encoding at least a NELL 1 peptide in frame with a nucleic acid encoding a secretory signal peptide; transfecting a ma
What is claimed is: 1. A method of expressing a functional peptide in a mammalian cell, said method comprising: providing a nucleic acid construct including at least a nucleic acid encoding at least a NELL 1 peptide in frame with a nucleic acid encoding a secretory signal peptide; transfecting a mammalian cell with said nucleic acid construct; culturing said mammalian cell under conditions that permit expression of the NELL 1 peptide; optionally collecting NELL 1 peptide secreted from the cell line; optionally substantially purifying the NELL 1 peptide; and optionally testing the activity of the NELL 1 peptide to induce bone formation, wherein the secretory signal peptide is selected from the group consisting of a melittin signal sequence, a drosphila immunoglobulin-binding protein signal sequence, an equine interferon-gamma (elFN-gamma) signal peptide, a snake phospholipase A2 inhibitor signal peptide, a human lysozyme signal peptide, and a chicken lyzozyme signal peptide. 2. The method of claim 1, wherein said mammalian cell is a COS7 cell. 3. The method of claim 1, wherein the nucleic acid encoding NELL 1 is selected from the group comprising: SEQ ID NO:1, SEQ ID NO:3, or SEQ ID NO:5. 4. The method of claim 1, wherein the NELL 1 peptide is selected from the group comprising: SEQ ID NO:2, SEQ ID NO:4, or SEQ ID NO:6. 5. A nucleic acid construct for expressing a NELL 1 peptide in a mammalian cell, said nucleic acid construct comprising at least a nucleic acid encoding at least a NELL 1 peptide in frame with a nucleic acid encoding a secretory signal peptide, wherein the secretory signal peptide is selected from the group consisting of a melittin signal sequence, a drosphila immunoglobulin-binding protein signal sequence, an equine interferon-gamma (elFN-gamma) signal peptide. a snake phospholipase A2 inhibitor signal peptide, a human lysozyme signal peptide, and a chicken lyzozyme signal peptide. 6. The nucleic acid construct of claim 5, wherein the nucleic acid encoding NELL 1 is selected from the group comprising: SEQ ID NO:1, SEQ ID NO:3, or SEQ ID NO:5. 7. The nucleic acid construct of claim 5, wherein the NELL 1 peptide is selected from the group comprising: SEQ ID NO:2, SEQ ID NO:4, or SEQ ID NO:6. 8. A cell line for expressing a functional NELL 1 peptide, said cell line including a nucleic acid construct comprising at least a nucleic acid encoding at least a NELL 1 peptide in frame with a nucleic acid encoding a secretory signal peptide, wherein the secretory signal peptide is selected from the group consisting of a melittin signal sequence, a drosphila immunoglobulin-binding protein signal sequence, an equine interferon-gamma (elFN-gamma) signal peptide, a snake phospholipase A2 inhibitor signal peptide, a human lysozyme signal peptide, and a chicken lyzozyme signal peptide. 9. The cell of claim 8, wherein said cell is a mammalian cell. 10. The cell of claim 9, wherein said cell is a COS7 cell. 11. The cell of claim 8, wherein the secretory signal peptide is a NELL peptide signal sequence. 12. The cell of claim 8, wherein the nucleic acid encoding NELL 1 peptide is selected from the group comprising: SEQ ID NO:1, SEQ ID NO:3, or SEQ ID NO:5. 13. The cell of claim 8, wherein the NELL 1 peptide is selected from the group comprising: SEQ ID NO:2, SEQ ID NO:4, or SEQ ID NO:6.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (19)
Afar Daniel E. ; Hubert Rene S. ; Leong Kahan ; Raitano Arthur B. ; Saffran Douglas C. ; Jakobovits Aya, BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells.
Jefferies Steven R. (5802 Leith Walk Baltimore MD 21239) Gutmann James L. (10112 Daventry Dr. Cockeysville MD 21030) Heatfield Barry M. (33 Penny La. Baltimore MD 21209), Collagen-enzyme conjugates that exhibit no inflammatory response and method for making the same.
Charles Petrie ; Mark V. Craig ; Nand Baindur ; Kirk G. Robbins ; Scott M. Harris ; Maria Kontoyianni ; Gregory R. Mundy, Compositions and methods for treating bone deficit conditions.
Yim Kalvin W. K. (N. andover MA) Huberty Michael C. (Andover MA) Northey ; Jr. Richard P. (Ipswich MA) Schrier Jay A. (Andover MA), Formulations for delivery of osteogenic proteins.
Beertsen Wouter (Santpoort Zuid NLX) van den Bos Theo (Zeist NLX), Implant materials having a phosphatase and an organophosphorus compound for in vivo mineralization of bone.
Peterson Dale R. ; Nousek-Goebl Nancy, Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration.
Kuberasampath Thangavel (Medway MA) Cohen Charles M. (Medway MA) Oppermann Hermann (Medway MA) Ozkaynak Engin (Milford MA) Rueger David C. (Hopkinton MA) Pang Roy H. L. (Etna NH), Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.